Neil Parkin

发表

The introduction of QFD in a UK original equipment manufacturer

David Stewardson, Matthew Linsley, Joseph Chan, 2002 .

TECHNICAL COMMENT ABSTRACTS

Ram Samudrala, Sebastian Bonhoeffer, Christos J. Petropoulos, 2006 .

Altered Substrate Specificity of Drug-Resistant Human Immunodeficiency Virus Type 1 Protease

Sami Mahrus, Neil Parkin, Dustin J Maly, 2002, Journal of Virology.

Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens.

Neil Parkin, N. Parkin, R. Colonno, 2004, The Journal of infectious diseases.

Hepatitis C virus drug resistance–associated substitutions: State of the art summary

Tara L. Kieffer, Neil Parkin, Oliver Lenz, 2015, Hepatology.

A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism

Eoin Coakley, Monique Nijhuis, Colombe Chappey, 2007, PLoS medicine.

Vertical transmission of X4-tropic and dual-tropic HIV-1 in five Ugandan mother–infant pairs

Wei Huang, Neil Parkin, Eric Stawiski, 2009, AIDS.

HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

Tulio de Oliveira, Meg Doherty, Deenan Pillay, 2017, The Lancet. Infectious diseases.

HIV-1 tropism and survival in vertically infected Ugandan infants.

Wei Huang, Deborah Donnell, Neil Parkin, 2008, The Journal of infectious diseases.